secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2024-06-20T23:59:59+00:00
Accession:  0001213900-24-054284
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics announces 1-for-8 reverse stock split effective June 20, 2024
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-8 ratio effective 12:01 a.m. ET on June 20, 2024.
- Outstanding shares reduced from ~4,511,756 to ~563,969; no fractional shares issued.
- Fractional shareholders receive cash payment based on average closing price over 10 trading days ending June 17.
- Ticker BJDX unchanged; new CUSIP 095633400; equity awards and warrants adjusted proportionately.
- Continental Stock Transfer is exchange agent; book-entry holders need no action.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390024054284/0001213900-24-054284-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390024054284/ea0208068-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-054284

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer